The U.S. SEC is on track to adopt new rules that will mandate that private equity and hedge funds disclose quarterly performance, fees and expenses
: It’s ‘crunch time’ for unionized auto workers, but this is not UPS
Talks between unionized workers and Big Three auto makers progress slowly ahead of the current contract’s Sept. 14 expiration, in contrast with recent labor successes.
: Nike’s stock falls with sporting retailers and chalks up longest losing streak on record
Nike’s stock has fallen for 10 straight sessions, marking its longest losing streak.
Commodities Corner: Nuclear power could see its biggest expansion in decades, leading to increased demand for uranium
Prices for uranium have reached their highest level in more than a year, providing an opportunity for investors looking to capitalize on bets that global worries surrounding climate change will boost demand for the energy source.
: Foot Locker sees softer-than-expected sales, weaker start to back-to-school
“Sales have been softer than expected through the first half,” said Foot Locker CEO Mary Dillon
Therese Poletti’s Tech Tales: These AI-chip startups hope to challenge Nvidia, but it may take some time
As investors focus on Nvidia earnings, other chip startups hope to eventually gain some of the AI space from the chip maker.
The Margin: DVD giveaway: Netflix to let people keep the DVDs they rented
Netflix is finally ending its DVD shipping service — and it’s not asking for its discs back
The Human Cost: Worried about price increases and global supplies, this San Francisco chef is stocking up on rice
Severe weather conditions, such as floods in China, and trade restrictions in India could lead to a shortage in rice, some analysts have warned.
Economic Report: U.S. created 306,000 fewer jobs in 2022 and early 2023 than initially reported
The U.S. economy has created millions of jobs since 2022, but the pace of hiring wasn’t quite as strong as it seemed.
Encore: The cost of healthcare is out of control, hurting programs for the elderly and the vulnerable
Big Pharma has a legislative blitz to prevent Medicare from negotiating drug prices.
- « Previous Page
- 1
- …
- 246
- 247
- 248
- 249
- 250
- …
- 1275
- Next Page »